BioSpace News Archive

The Barer Institute, a collaborative cancer drug development initiative of Rafael Holdings, Inc., announced the slate of highly regarded scientific and business leaders that will serve as its founding Board of Directors.

Subsequent to Closing of the $490M Transaction, RTI Surgical Will Be a Global Pure Play Spine Company Targeting Double-Digit Growth

Thousands of Home-based Care Professionals Surveyed for Industry Insights

First Company Developing a KRAS(G12C) Inhibitor to Announce Multi-Platform Companion Diagnostics

Clinical partnership of phase 1/1b combination clinical trial with Genome & Company’s GEN-001, microbiome-based immuno-oncology therapy, and avelumab (BAVENCIO®), Merck KGaA, Darmstadt, Germany and Pfizer Inc.'s anti-PD-L1 antibody in oncology indications

First agreements with statutory health insurances utilize bluebird’s innovative value-based payment model and provide coverage for ZYNTEGLO for up to 50% of patients in Germany

Achieve Life Sciences, Inc., University of Bristol, and Oracle Corporation announced the outcome of a study using Oracle’s high-performance cloud infrastructure to potentially improve the speed of drug discovery and development of new treatments.

Emergent BioSolutions Inc. announced that it has received agreement from the European Medicines Agency to pursue its proposed development plan for its chikungunya virus virus-like particle vaccine candidate.

Natus Medical Incorporated, a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, reaffirmed fourth quarter 2019 guidance and announced that Jonathan Kennedy, President and Chief Executive Officer will present at the 38th Annual JP Morgan Healthcare Conference in San Francisco.

Organogenesis Holdings Inc., a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, reported preliminary revenue results for its fourth quarter and fiscal year ended December 31, 2019.